The preclinical candidate indole-2-carboxamide improves immune responses to Mycobacterium tuberculosis infection in healthy subjects and individuals with type 2 diabetes
2019 ◽
Vol 23
(2)
◽
pp. 161-170
◽
2019 ◽
Vol 9
◽
2020 ◽
2020 ◽
Vol 22
(8)
◽
pp. 303-311
◽